For the quarter ending 2026-03-31, ZYME made $2,408K in revenue. -$44,648K in net income. Net profit margin of -1854.15%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development collaborations | 2,408 | 2,515 | 27,614 | 48,726 |
| Research and development | 34,457 | 31,235 | 35,578 | 34,449 |
| Impairment on ipr&d (note 6) | - | 0 | 0 | 0 |
| General and administrative | 15,069 | 15,432 | 14,146 | 14,951 |
| Total operating expenses | 49,526 | 46,667 | 49,724 | 49,400 |
| Loss from operations | -47,118 | -44,152 | -22,110 | -674 |
| Interest income | 2,711 | 2,975 | 3,529 | 3,426 |
| Interest expense related to sale of future royalties | 2,066 | - | - | - |
| Other income, net | 120 | -302 | 315 | -621 |
| Total other income, net | 765 | 2,673 | 3,844 | 2,805 |
| Loss before income taxes | -46,353 | -41,479 | -18,266 | 2,131 |
| Income tax recovery (expense) | -2,191 | -270 | 1,336 | -186 |
| Net loss | -44,162 | -41,209 | -19,602 | 2,317 |
| Unrealized (gain) income on available for sale securities, net of tax of 0 | -486 | -29 | 290 | 66 |
| Total other comprehensive (gain) income | -486 | -29 | 290 | 66 |
| Comprehensive loss | -44,648 | -41,238 | -19,312 | 2,383 |
| Basic EPS | -0.59 | -0.547 | -0.26 | 0.03 |
| Diluted EPS | -0.59 | -0.563 | -0.26 | 0.03 |
| Basic Average Shares | 74,668,790 | 75,343,622 | 75,767,778 | 75,337,168 |
| Diluted Average Shares | 74,694,762 | 73,273,534 | 75,775,214 | 77,378,449 |
Zymeworks Inc. (ZYME)
Zymeworks Inc. (ZYME)